New Trends and Advances in Molecular Targeted Therapy for Cancer
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell and Gene Therapy".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 13
Special Issue Editors
Interests: epigenetics; immuno-oncology; tyrosine kinases; small molecule inhibitors; prostate cancer
2. School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2050, Australia
3. Intelligent Polymer Research Institute and Institute of Innovative Materials, AIIM Facility, Faculty of Engineering and Information Sciences, University of Wollongong, Fairy Meadow, NSW 2519, Australia
Interests: biomedical engineering; regenerative medicine (including stem cells); cancer therapy; medical devices; tissue engineering; tissue modelling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Conventional chemotherapy has evolved drastically over the past decade in order to address the longstanding challenge of cancer heterogeneity aiming for better progression-free survival. The development of targeted therapy that aims to inhibit specific targets/proteins has revolutionized the cancer therapy, leading to side-effect elimination and enhanced efficacy. With small-molecule inhibitors and monoclonal antibodies majorly constituting the majority of targeted cancer therapies, simultaneous effects on cancer cells and immune cells are achieved by nullifying major intrinsic resistance mechanisms. This also opens the venue for introducing novel treatment combinations and antibody-drug conjugates.
This Special Issue aims to highlight the current landscape of targeted therapies against prevalent cancers, especially the ongoing combinational strategies that hold a promise of better outcomes and improved quality of life. This Special Issue will be providing a panoramic view of the existing options, its challenges, and future potential that will deepen our understanding regarding enhanced clinical benefits in cancer patients.
We look forward to receiving your contributions.
Dr. Dhivya Sridaran
Prof. Dr. Jeremy M. Crook
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer targeted therapy
- antibodies
- small-molecule inhibitors
- antibody–drug conjugates
- combination therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
